share_log

Needham Reiterates Buy on Avadel Pharmaceuticals, Maintains $22 Price Target

Needham Reiterates Buy on Avadel Pharmaceuticals, Maintains $22 Price Target

Needham重申对avadel pharmaceuticals的买入评级,维持22美元的价格目标。
Benzinga ·  10/18 17:53

Needham analyst Ami Fadia reiterates Avadel Pharmaceuticals (NASDAQ:AVDL) with a Buy and maintains $22 price target.

Needham分析师Ami Fadia重申对avadel pharmaceuticals(纳斯达克:AVDL)的买入评级,维持22美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发